Plain-English translation of NCT06611150 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing , a chemotherapy medication, to see if it can be safely combined with radiation therapy to treat advanced nasopharyngeal cancer (a type of throat cancer). Researchers want to find the best dose of this medication that patients can tolerate when given alongside radiation. The goal is to understand how this treatment combination works so it can be studied more broadly in future trials.
Nasopharyngeal cancer is a serious disease that requires strong treatment, and researchers believe combining this medication with radiation might help patients better than radiation alone. This early-stage trial is designed to find the safest and most effective dose before testing the combination in larger groups of patients.
You likely qualify if…
You likely don't qualify if…
You would first receive induction chemotherapy (an initial round of chemotherapy before the main treatment), then enter the main study phase where you receive the new medication alongside your radiation therapy. The dose of the medication will be gradually increased across groups of participants to find the safest level. You'll have regular visits to monitor how well you tolerate the treatment and watch for side effects.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China